Cognetivity Neurosciences Ltd. Stock

Stocks

CGNSF

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded
Delayed OTC Markets 12:19:29 2026-06-25 pm EDT 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for Cognetivity Neurosciences Ltd. -.--% -

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 1.2M 851K 748K 695K 638K 81.96M 1.22M 8.26M 3.23M 40.3M 3.2M 3.13M 139M P/E 2022
-2.9x
P/E 2023 -2.8x
Enterprise Value 245K 174K 153K 142K 130K 16.77M 249K 1.69M 660K 8.24M 654K 639K 28.5M EV / Sales 2022
-
EV / Sales 2023 437,922,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.16
5 years 0
Extreme 0
0.78
10 years 0
Extreme 0
1.12
Manager TitleAgeSince
Chief Executive Officer 45 2013-03-31
Compliance Officer 67 2017-12-20
Director TitleAgeSince
Director/Board Member 45 2016-12-31
Director/Board Member 67 2017-12-20
Date Insider Type Main position Quantity % Market Cap.
4/15/24 Option

Founder

600,000 0.6697%
4/15/24 Option

Founder

600,000 0.6697%
6/23/23 Sell

Founder

1,108,160 1.3030%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%-.--% - - 93
+3.60%-3.87%-35.14%-4.46% 30.25B
+1.51%-12.61%-49.37%+138.80% 11.68B
+2.26%-0.95%-27.00%+59.74% 5.28B
+3.73%-1.14% - - 2.08B
+2.00%-6.35%+44.79%-31.98% 1.86B
+3.99%+0.52% - - 1.72B
-0.08%-3.34%-37.93% - 1.03B
+2.97%+0.23%+32.99%+108.18% 865M
-4.53%-4.82%-45.89%-57.53% 723M
Average -8.40%-5.04%-16.79%+35.46% 5.55B
Weighted average by Cap. +2.76%-6.65%-33.71%+35.40%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 3.1 0.05 0.31 0.12 1.53 0.12 0.12 5.27
Net income -13.13M -9.32M -8.19M -7.61M -6.99M -898M -13.33M -90.41M -35.32M -441M -34.99M -34.24M -1.53B -7.43M -5.28M -4.64M -4.31M -3.96M -508M -7.55M -51.2M -20M -250M -19.82M -19.39M -864M
Net Debt -82.43K -58.53K -51.41K -47.81K -43.87K -5.64M -83.7K -568K -222K -2.77M -220K -215K -9.58M -953K -677K -595K -553K -507K -65.2M -968K -6.57M -2.57M -32.05M -2.54M -2.49M -111M
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGNSF Stock